Early research (Phase 1)Ended earlyNCT05676697
What this trial is testing
PI3K Delta Inhibitor in Relapsed / Refractory Autoimmune Hemolytic Anemia Patients After Receiving Two or More Lines of Therapy
Who this might be right for
Autoimmune Hemolytic AnemiaFailure of Two Rounds of Treatment
Institute of Hematology & Blood Diseases Hospital, China 4